• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Jun 1988; 85(12): 4526–4529.
PMCID: PMC280463

Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses.

Abstract

Human coronavirus OC43 and bovine coronavirus elute from agglutinated chicken erythrocytes when incubated at 37 degrees C, suggesting the presence of a receptor-destroying enzyme. Moreover, bovine coronavirus exhibits an acetylesterase activity in vitro using bovine submaxillary mucin as substrate similar to the enzymatic activity found in influenza C viruses. Furthermore, pretreatment of erythrocytes with either influenza C virus or bovine coronavirus eliminates subsequent binding and agglutination by either coronaviruses or influenza C virus, whereas binding of influenza A virus remains intact. In addition, hemagglutination by coronaviruses can be inhibited by pretreatment of erythrocytes with Arthrobacter ureafaciens or Clostridium perfringens neuraminidase or by addition of sialic acid-containing gangliosides. These results suggest that, like influenza C viruses, human coronavirus OC43 and bovine coronavirus recognize O-acetylated sialic acid or a similar derivative as cell receptor.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • McIntosh K, Kapikian AZ, Turner HC, Hartley JW, Parrott RH, Chanock RM. Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol. 1970 Jun;91(6):585–592. [PubMed]
  • Monto AS, Lim SK. The Tecumseh study of respiratory illness. VI. Frequency of and relationship between outbreaks of coronavirus infection. J Infect Dis. 1974 Mar;129(3):271–276. [PubMed]
  • McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A. 1967 Apr;57(4):933–940. [PMC free article] [PubMed]
  • Stair EL, Rhodes MB, White RG, Mebus CA. Neonatal calf diarrhea: purification and electron microscopy of a coronavirus-like agent. Am J Vet Res. 1972 Jun;33(6):1147–1156. [PubMed]
  • Hogue BG, King B, Brian DA. Antigenic relationships among proteins of bovine coronavirus, human respiratory coronavirus OC43, and mouse hepatitis coronavirus A59. J Virol. 1984 Aug;51(2):384–388. [PMC free article] [PubMed]
  • Lai MM, Stohlman SA. RNA of mouse hepatitis virus. J Virol. 1978 May;26(2):236–242. [PMC free article] [PubMed]
  • Wege H, Siddell S, ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol. 1982;99:165–200. [PubMed]
  • Vlasak R, Krystal M, Nacht M, Palese P. The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities. Virology. 1987 Oct;160(2):419–425. [PubMed]
  • Herrler G, Rott R, Klenk HD, Müller HP, Shukla AK, Schauer R. The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J. 1985 Jun;4(6):1503–1506. [PMC free article] [PubMed]
  • Kaye HS, Dowdle WR. Some characteristics of hemagglutination of certain strains of "IBV-like" virus. J Infect Dis. 1969 Nov;120(5):576–581. [PubMed]
  • Hierholzer JC, Palmer EL, Whitfield SG, Kaye HS, Dowdle WR. Protein composition of coronavirus OC 43. Virology. 1972 May;48(2):516–527. [PubMed]
  • Zakstel'skaia L Ia, Sheboldov AV, Molibog EV. Nekotorye aspekty vzaimodeistviia koronavirusov OC38 i OC43 s éritrotsitami. Vestn Akad Med Nauk SSSR. 1972;27(6):40–43. [PubMed]
  • Bingham RW, Madge MH, Tyrrell DA. Haemagglutination by avian infectious bronchitis virus-a coronavirus. J Gen Virol. 1975 Sep;28(3):381–390. [PubMed]
  • Sugiyama K, Amano Y. Hemagglutination and structural polypeptides of a new coronavirus associated with diarrhea in infant mice. Arch Virol. 1980;66(2):95–105. [PubMed]
  • Boyle JF, Weismiller DG, Holmes KV. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J Virol. 1987 Jan;61(1):185–189. [PMC free article] [PubMed]
  • Sturman LS, Holmes KV, Behnke J. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol. 1980 Jan;33(1):449–462. [PMC free article] [PubMed]
  • Graves PN, Schulman JL, Young JF, Palese P. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology. 1983 Apr 15;126(1):106–116. [PubMed]
  • Ritchey MB, Palese P, Kilbourne ED. RNAs of influenza A, B, and C viruses. J Virol. 1976 May;18(2):738–744. [PMC free article] [PubMed]
  • Palese P, Schulman J. Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3'-methoxyphenyl)-n-acetylneuraminic acid to identify cloned populations. Virology. 1974 Jan;57(1):227–237. [PubMed]
  • Sharpee RL, Mebus CA, Bass EP. Characterization of a calf diarrheal coronavirus. Am J Vet Res. 1976 Sep;37(9):1031–1041. [PubMed]
  • Pokorný J, Brůcková M, Rýc M. Biophysical properties of coronavirus strain OC 43. Acta Virol. 1975 Apr;19(2):137–142. [PubMed]
  • HIRST GK. The relationship of the receptors of a new strain of virus to those of the mumps-NDV-influenza group. J Exp Med. 1950 Feb;91(2):177–184. [PMC free article] [PubMed]
  • Kendal AP. A comparison of "influenza C" with prototype myxoviruses: receptor-destroycing activity (neuraminidase) and structural polypeptides. Virology. 1975 May;65(1):87–99. [PubMed]
  • Ohuchi M, Homma M, Muramatsu M, Ohyama S. Properties of the erythrocyte receptors for influenza C virus. Microbiol Immunol. 1978;22(4):197–203. [PubMed]
  • Rogers GN, Herrler G, Paulson JC, Klenk HD. Influenza C virus uses 9-O-acetyl-N-acetylneuraminic acid as a high affinity receptor determinant for attachment to cells. J Biol Chem. 1986 May 5;261(13):5947–5951. [PubMed]
  • Herrler G, Rott R, Klenk HD. Neuraminic acid is involved in the binding of influenza C virus to erythrocytes. Virology. 1985 Feb;141(1):144–147. [PubMed]
  • Sturman LS, Holmes KV. Characterization of coronavirus II. Glycoproteins of the viral envelope: tryptic peptide analysis. Virology. 1977 Apr;77(2):650–660. [PubMed]
  • Deregt D, Babiuk LA. Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins. Virology. 1987 Dec;161(2):410–420. [PubMed]
  • Sugano K, Saito M, Nagai Y. Susceptibility of ganglioside GM1 to a new bacterial neuraminidase. FEBS Lett. 1978 May 15;89(2):321–325. [PubMed]
  • Rauvala H. Monomer-micelle transition of the ganglioside GM1 and the hydrolysis by Clostridium perfringens neuraminidase. Eur J Biochem. 1979 Jul;97(2):555–564. [PubMed]
  • Higa HH, Rogers GN, Paulson JC. Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-, N-glycollyl-, and N,O-diacetylneuraminic acids. Virology. 1985 Jul 15;144(1):279–282. [PubMed]
  • Wiley DC, Skehel JJ. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem. 1987;56:365–394. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...